Balling M, Roepstorff OG, Gerds TA, Varbo A, et al. Risk reduction of ASCVD attributed to lowering of remnant cholesterol from statins, fibrates, APOC3 inhibitors, and ANGPTL3 inhibitors: a cohort study. Atherosclerosis 2025;409:120471.
PMID: 40839980